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1. Introduction 
Site-directed and random mutagenesis have been useful tools in molecular biology. The 
application of directed mutagenesis in medically important fungi has been limited by the 
availability of molecular genetic techniques. Even species in which efficient genetic 
transformation methodologies exist, mutagenesis approaches were sparsely used due to 
diploidism. Lack of genetic tools hindered understanding of virulence mechanisms of 
medically important fungi. With the arrival of whole-genome sequencing, as well as 
improved techniques of genetic manipulation, the ability to address these questions is 
improving. A comprehensive review of mutagenesis in pathogenic fungi is outside the 
scope of this review, so not all studies were included.  The intent of this review is to educate 
the reader on applications of site-directed and random insertional mutagenesis in medically 
important fungi in order to provide ideas for novel approaches to address major issues in 
pathogenic fungal research. 
2. Site-directed mutagenesis 
Site-directed mutagenesis has been exploited to understand signaling pathways, 
mechanisms of drug resistance, and identification of promoter DNA binding sites. 
Applications used less frequently have included protein localization and function of specific 
genes. In most instances, the site of the mutation was selected due to homology to model 
species or mammalian genes. 
2.1 Signaling pathways 
The most commonly reported application of site-directed mutants is the construction of 
dominant-negative and dominant-active alleles. The ability to make dominant-active alleles 
is particularly useful in diploid strains, since both endogenous alleles do not have to be 
disrupted. The amino acids chosen for mutation are often based on homology to 
Saccharomyces cerevisiae or Aspergillus nidulans. Although the roles of genes in signaling 
pathways were identified in model fungi, the regulation and downstream effects of these 
pathways are often very different in medically important fungi.  
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2.1.1 Phosphomimetics 
The introduction of an amino acid substitution so the residue acts as constitutively 
phosphorylated or non-phosphorylated is a common technique to study cellular processes. 
Phosphomimetics have been used to study MAPK, cAMP-PKA, calcineurin, and  two–
component signaling, as well as cytokinesis and the heat shock response, in medically 
important fungi (Bockmühl and Ernst, 2001; Fox and Heitman, 2005; Hicks et al., 2005; Li et 
al., 2008; Menon et al., 2006; Nicholls et al., 2011).  
The cAMP-PKA pathway regulates multiple cellular processes in eukaryotes. cAMP levels 
are regulated by phosphodiesterases (PDE1, PDE2), which in turn are regulated by protein 
kinase A (PKA) in some species. In Cryptococcus neoformans, the cAMP pathway is involved 
in multiple cellular processes, including virulence factor expression (melanin and capsule 
formation) (Hicks et al., 2005). Since the role in cAMP degradation and regulation by PKA of 
PDE1 and PDE2 differ among species, the goal of this study was to learn the functions of the 
PDEs in C. neoformans. In order to identify if PDE1 was regulated by PKA through 
phosphorylation, a site-directed mutation in the PDE1 at a putative PKA phosphorylation 
site was introduced based on work in Saccharomyces. Site-directed mutagenesis was 
performed by overlap PCR (Section 2.7), and the product was ligated into a C. neoformans 
transformation vector. The predicted outcome was an inactive PDE1 and, thus, increased 
activation of the PKA pathway. In this way, the use of site-directed mutagenesis validated 
that PKA directly regulated the activation of PDE1 in C. neoformans (Hicks et al., 2005).  
Putative phosphorylated residues have not always been identified previously in model 
fungi. Consequently, in silico analysis can be utilized to identify putative phosphorylation 
sites (Bockmühl and Ernst, 2001; Li et al., 2008). In silico analysis predicted certain threonine 
residues as phosphorylation sites in the Candida albicans APSES protein Efg1p. These sites 
were mutated. Phenotypic analysis demonstrated that the mutations differentially affected 
morphogenesis, an important virulence attribute of C. albicans (Bockmühl and Ernst, 2001).  
Unlike previous studies, target residues in the two-component response regulator, Ssk1p, 
were identified by sequence comparison to a bacterial response regulator (Menon et al., 
2006). Invariant aspartic acid residues were substituted using site-directed mutagenesis.  
This study demonstrated that phosphorylation of two different residues affects regulation of 
different cellular processes involved in virulence (Menon et al., 2006).   
2.1.2 G protein signaling 
Another common application for site-directed mutagenesis has been G protein signaling. In 
Aspergillus fumigatus, asexual sporulation results in release of spores that are inhaled by 
man, which can lead to serious manifestations. In the non-pathogen, Aspergillus nidulans,  it 
was known that G protein signaling pathways were responsible for both vegetative growth 
and conidiation. Activation of flbA is required for conidiation, and this was probably 
through the activation of the GTPase activity of the G alpha protein FadA.  Mah et al. (2006) 
used this framework to determine if similar regulation occurred in the pathogen A. 
fumigatus (Mah and Yu, 2006). They were able to confirm that Afflb regulated the G protein 
signaling through GpaA (homolog of FadA). Gene disruption and random chemical 
mutagenesis confirmed the role of Afflb in conidiation. Dominant-active and dominant-
negative mutant alleles of gpaA (made by overlap PCR) demonstrated that it is a 
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downstream target in this pathway. Interestingly conidiation appeared even in the absence 
of Afflb (Mah and Yu, 2006), which may aid in dissemination.  
As in Aspergillus, G protein signaling is also responsible for cellular differentiation  in C. 
albicans. Much of the initial molecular dissection of the signaling pathways involved in 
morphogenesis was deciphered by constructing dominant-active and dominant-negative 
alleles of the G signaling proteins. Site-specific mutations were introduced in CDC42, RAC1, 
GPA2, RAS1 and RAS2 based on homology to Saccharomyces and mammalian G proteins 
(Bassilana and Arkowitz, 2006; Feng et al., 1999; Sanchez-Martinez and Perez-Martin, 2002; 
vandenBerg et al., 2004). The mutant alleles were introduced into exogenous loci under the 
expression of constitutive or regulatable promoters (Bassilana and Arkowitz, 2006; Feng et 
al., 1999; Sanchez-Martinez and Perez-Martin, 2002). However, since CDC42 is essential, the 
mutated alleles were introduced at the endogenous locus in a CDC42/cdc42 heterozygote 
(VandenBerg et al., 2004). These studies demonstrated the existence of different hyphal 
induction pathways, cross-talk between the MAPK and cAMP pathways, and distinction 
between growth and morphogenesis. 
2.2 Mechanisms of drug resistance  
Many fungal species present antifungal drug resistance in vivo. Studies have enhanced our 
understanding of this resistance. In most species, drug resistance is due to increased 
expression of export channels and/or mutations in target genes of the antifungal agent. 
Further studies confirmed the importance of the mutations.  
The azoles interfere with ergosterol biosynthesis by targeting lanosterol 14 alpha-
demethylase (ERG11, CYP51). Mutations in the gene resulted in reduced binding by the 
azole compound. Mutational hotspots were identified by sequencing the gene of interest 
from fungal strains isolated from patients or strains that have been passaged in the presence 
of the drug in vitro.  It was then necessary to confirm that the mutation correlated with 
reduced susceptibility to the drug. Site-directed mutagenesis is an ideal method for 
validation. Due to homology of the ERG11 gene among fungal species, many studies were 
performed in the more genetically malleable yeasts, S. cerevisiae or Pichea pastoris (Alvarez-
Rueda et al., 2011). These studies confirmed that the mutated expressed protein is more or 
less susceptible to drug, but they do not definitively prove that the mutation was the reason 
for the clinical resistance. With the advent of genetic transformation techniques in medically 
important fungi, it is now possible to perform these experiments in the appropriate fungal 
host.  
The most studied gene is ERG11 in C. albicans, reviewed in Morio et al. (2010). Over 144 
amino acid substitutions have been identified. It is less clear how many of these contribute 
to in vivo resistance. Additionally, some mutations may result from in vitro manipulations.   
A recent screen of azole-susceptible and resistant clinical isolates demonstrated that 
mutations are associated with both susceptibility and reduced susceptibility. Only 18% of 
isolates had no polymorphisms (Morio et al., 2010). These results highlighted the need to 
confirm that a specific mutation correlated with acquisition of resistance. In C. albicans, this 
has been approached by site-directed mutagenesis. Initial studies cloned the ERG11 open 
reading frame (ORF) in a plasmid and then used PCR to introduce site-directed mutations. 
The PCR products were ligated into a S. cerevisiae expression vector. S. cerevisiae (azole 
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susceptible strain) was transformed with plasmids containing the mutated C. albicans ERG11 
gene and tested in a series of assays for reduced azole susceptibility. In this manner, azole 
resistance was correlated with specific amino acid substitutions (Kakeya et al., 2000; Lamb et 
al., 2000; Lamb et al., 1997; Sanglard et al., 1998; Sheng et al., 2010). Direct mutagenesis of the 
ERG11 gene in C. albicans has not been reported. However, direct mutagenesis of the azole-
target gene cyp51A, was performed in A. fumigatus (Mellado et al., 2007; Snelders et al., 
2011). Two approaches were used. In the first study, mutated sequences were amplified by 
PCR from clinical isolates that demonstrated reduced susceptibility to itraconazole (Mellado 
et al., 2007). Previously it was known that itraconazole resistance correlated with specific 
amino acid mutations at G54 and M220 (See Table 1 in the chapter by Figurski et al. for the 
amino acid codes). However, this study identified a new mutation site (L98H) in conjunction 
with a duplication in the promoter sequence.  In order to confirm the importance of these 
mutations, an azole-susceptible strain was transformed with the mutated allele; and 
transformants were plated on itraconazole (Mellado et al., 2007). Although the importance 
of the mutation sites were confirmed, the transformation selection criteria were not efficient. 
A second study expanded upon this approach and used 3-D modeling to determine a 
mechanistic reason for the azole resistance conferred by the mutations (Snelders et al., 2011).   
Specific amino acids were substituted in the cyp51A using the QuickChange XL Site-
Directed Mutagenesis Kit (Stratagene) (Section 2.7). The appropriate PCR products were 
cloned into a vector that contained a hygromycin resistance marker and flanking sequences 
for introduction into the endogenous cyp51A site.  Therefore, positive transformants were 
selected on hygromycin and further tested for azole resistance/susceptibility phenotypes. 
Consequently, the inclusion of a dominant selective marker improved the efficiency of 
screening transformants (Snelders et al., 2011). To further expand identification of potential 
mutation sites, the same experimental approach could be used by subjecting the cyp51A 
gene to random PCR-directed mutagenesis (Palmer and Sturtevant, 2004) and thereby 
identify new mutation sites that confer altered susceptibility. 
2.3 Promoter response elements  
Mutagenesis is a common approach to identify DNA binding sites in promoters. Nested 
deletions are probably the most commonly reported method used in the medically 
important fungi. Site-directed mutagenesis has been used to introduce point mutations in 
the hapB promoter in A. nidulans; so this approach may be used in A. fumigatus in the future 
(Brakhage and Langfelder, 2002). Site-directed mutagenesis has been used to identify 
putative promoter elements in chitin synthases (CHS2, CHS8) in C. albicans (Lenardon et al., 
2009). The significance of this study is that chitin synthases are up-regulated in response to 
cell wall stress and thus are important for fungal survival. In this study, the promoters of 
CHS2 and CHS8 were mutated by site-directed mutagenesis or nested deletions. The 
selected sites were chosen due to previous studies or by in silico analysis. The mutated 
Candida promoter sequences were ligated upstream of the Streptococcus thremophilus lacZ 
gene. If the mutated site in the promoter element were important for a specific cell wall 
stress, lacZ would not be induced; and colonies would be white instead of blue on X-gal-
containing medium. (X-gal is 5-bromo-4-chloro-indolyl-β-D-galactopyranoside.) The chosen 
potential sites reflected induction of several pathways and included known binding motifs. 
Mutations of individual promoter elements selected by in silico analysis had no effect on 
expression. Consequently, they performed nested deletions using exonuclease III digestion 
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of restriction-digested plasmids containing the CHS2 and CHS8 genes. These mutated 
promoters were introduced into Candida by transformation, and induction of the lacZ 
reporter was assayed after stresses. In this manner they were able to identify regions, but 
not specific regulatory elements, in the CHS2 and CHS8 promoters that responded to cell 
wall stressors (Lenardon et al., 2009). In order to determine which signaling pathways acted 
upon these promoters, the mutated CHS2 and CHS8 constructs were introduced into C. 
albicans signaling pathway deletion mutants. These studies demonstrated that the cell wall 
integrity, calcineurin, and HOG (osmotic sensing) pathways mediated expression through 
the CHS2 promoter; only the cell wall integrity pathway affected CHS8-mediated expression 
(Lenardon et al., 2009). A pitfall of the deletion method is that it does not identify exact 
residues. It is possible to lose structural consistency, and it may delete other regulatory 
elements. In order to identify appropriate binding sites, random mutagenesis of CHS2 and 
CHS8 promoters by XL1-Red (a mutator strain of Escherichia coli useful for mutating cloned 
fragments) could have been performed (Palmer and Sturtevant, 2004). The ensuing 
transformants could be quickly screened on cell wall stressor media.  
In another study, the authors wanted to identify the promoter binding sites in the pH 
responsive gene, PHR1, in C. albicans (Ramon and Fonzi, 2003). The pH response pathway 
had been well researched in A. nidulans. However, the promoter binding elements in the 
Aspergillus pH responsive gene (pacC) could not be translated to PHR1. Therefore, regions of 
DNA binding were identified in vitro by ChIP (Chromatin Immunoprecipitation Assay) and 
then confirmed by site-directed mutagenesis (Ramon and Fonzi, 2003).  
Site-directed mutagenesis and ChIP have also been used to identify the genes that a specific 
transcription factor binds. A good illustration is the gain-of-function allele of the 
transcription factor CAP1 that was constructed by site-directed mutagenesis and then 
analyzed in ChIP assays (Znaidi et al., 2009).  
2.4 Gene function-essential genes 
Surprisingly, site-directed mutagenesis has not been used extensively to determine the 
function of a gene. Gene disruption is routinely the method of choice to study gene function. 
However, this is not possible when studying the function of essential genes. The use of 
conditional promoters is often used. Results can sometimes be misleading, since phenotypic 
testing is performed under suboptimal growth conditions due to promoter-dependent 
nutritional constraints. Even so, expression of an essential gene under a conditional reporter 
does not allow complete analysis of multifunctional genes. Very few studies have taken 
advantage of directed mutagenesis of a specific gene.  
The first report of the use of site-directed mutagenesis of an essential and multifunctional 
gene was the signaling regulatory gene, BMH1 (14-3-3 gene). There is only one 14-3-3 
protein (Bmh1p) in C. albicans, and it is essential (Cognetti et al., 2002). Multiple approaches 
were attempted to express the gene under a regulatable promoter, but they were 
unsuccessful (Palmer et al., 2004). This may be because BMH1 regulates multiple cellular 
processes involved in growth, and the phenotypic studies were performed under 
suboptimal growth conditions due to promoter-dependent nutritional constraints. 
Therefore, BMH1 appeared to be an excellent candidate to test the feasibility of both site-
directed and random mutagenesis. Amino acid residues in the 14-3-3 allele required for 
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ligand binding, dimerization, and growth were reported for other eukaryotic species. Due to 
the high degree of conservation between 14-3-3 proteins, the same residues were selected for 
substitution in the C. albicans BMH1 allele. Six sites were chosen.  Transformants were 
screened for filamentation and growth defects (Palmer et al., 2004). Two approaches tested 
the applicability of random mutagenesis of the BMH1 allele (Palmer and Sturtevant, 2004). 
A plasmid containing the BMH1 allele was propagated in the E. coli XL-1 Red strain 
(Stratagene), which is deficient in multiple primary DNA repair pathways and thus 
introduces random mutations in the plasmid. Mutagenized plasmids were isolated after 11 
to 44 divisions and introduced into the remaining BMH1 locus in a BMH1 heterozygote 
strain. The second random mutagenesis approach was PCR-mediated. (DNA polymerases 
used for PCR can be mutagenic under certain conditions.) The BMH1 allele was subject to 
PCR amplification with an unbalanced nucleoside pool. The PCR products were ligated into 
a Candida transformation vector, and pools were introduced into the BMH1 heterozygote by 
transformation, as above.  The E. coli-mediated mutagenesis resulted in a higher efficiency of 
correct integration of the mutated allele than did the PCR-mediated method. Around 1400 
(1000 – E. coli-mediated; 368 – PCR-mediated) C. albicans transformants containing randomly 
mutagenized BMH1 alleles were screened under a variety of phenotypic stresses. These tests 
were rapid and easily visible; thus, they translated easily into a screen. Mutant alleles were 
isolated from transformants that demonstrated altered phenotypes and were sequenced. In 
the end, from 1000 E. coli- and 368 PCR-mutated colonies, 2 and 4 alleles, respectively (0.4%), 
were identified with altered coding sequences. That these mutations were responsible for 
the altered phenotypes was validated by constructing C. albicans strains isogenic for the site-
directed mutations, as described previously. While the efficiency of the random mutagenesis 
methods was lower than reported for bacteria, non-lethal mutants were identified. Thus, 
this is a valid approach to study gene function in fungi (Palmer and Sturtevant, 2004). The 
outcome of the site-directed and random mutagenesis approaches was a set of isogenic 
strains in which BMH1 or a mutant BMH1 allele was expressed under its own promoter at 
an exogenous locus. These strains were analyzed under a variety of environmental 
conditions reflecting stresses in the host. It was possible to discriminate between separate 
pathways involved in filamentation, growth, and survival in the host (Kelly et al., 2009; 
Palmer et al., 2004; Palmer and Sturtevant, 2004). Additional mutants may have been 
identified if transformants were screened in additional tests or in in vivo models. On the 
other hand, since BMH1 is an essential gene, there may be a limited number of amino acids 
that can be mutated and still result in a non-lethal allele. 
Site-directed mutagenesis was also used to decipher the role of the hemoglobin response 
gene (HBR1) in vegetative growth. It was known that HBR1 induced mating type genes, but 
mating is not an essential process in C. albicans (Peterson et al., 2011). Sites required for 
optimal growth and the oxidative stress response in the homologous gene in Saccharomyces 
were targeted in the C. albicans gene. The mutant alleles were introduced into a HBR1 
heterozygote and were regulated by the MET3 promoter. This study identified amino acid 
residues important for mating locus regulation, but not for vegetative growth. Thus, amino 
acids identified to be important in model fungal species do not always translate to related 
pathogenic fungi (Peterson et al., 2011). 
Essential genes are often prospective drug targets. One such gene is MET6. In C. albicans, 
Prasannan et al. (2009) constructed GST fusions of mutated C. albicans MET6 and expressed 
the fusion protein in a MET6 Saccharomyces mutant. A 3-D model that was modified from 
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the known crystallized structure of the Arabidopsis enzyme was used to select sites for 
mutation in MET6. Eight residues were chosen based on conservation across species and 
probability of being catalytic sites. Site-directed mutagenesis was introduced by the 
Quikchange kit from Stratagene. The mutant GST-Met6p fusion proteins demonstrated 
varied enzymatic activity validating the use of this approach in the design of new antifungal 
drugs (Prasannan et al., 2009).  
2.5 Gene function – genes with multiple functions 
The transcriptional regulator, EFG1, regulates multiple cellular processes in C. albicans. EFG1 
is a member of the APSES protein family. Although the domain that defines this family is 
known, the actual structure-function relationships were not understood. Thus, defined 
regions within and flanking the APSES domain were deleted. This was mediated by PCR. 
Instead of amino acid substitution, 15 – 103 nucleotides were deleted from within the EFG1 
gene, similar to what is done for promoter bashing (mutating promoters) (Noffz et al., 2008). 
A disadvantage to this approach is that it is not possible to discriminate if an altered 
phenotype is due to the compromise of protein structure or to the absence of protein 
expression. However, immunoblotting confirmed that the mutated protein was expressed in 
all mutants. Two mutants did express lower levels of Efg1p that could account for altered 
phenotypes (Noffz et al., 2008). Thus, it is important to confirm protein expression of 
mutants. The authors were able to associate specific regions of Efg1p with distinct cellular 
processes that it regulates. The deletion alleles were also used in over-expression and one-
hybrid (gene-fusion technology to identify a DNA-binding domain) experiments.  Thus, this 
approach was successful in determining structure – function relationships of an APSES 
protein (Noffz et al., 2008).  
2.6 Other applications  
Site-directed mutagenesis has been used to determine how GPI-tagged proteins discriminate 
between localization to the plasma membrane and cell wall (Mao et al., 2008). N and C 
termini of cell wall or plasma proteins were fused to GFP. The termini were subjected to 
truncation and mutagenesis. Localization of mutant alleles was examined by microscopy. 
One potential pitfall, however, is that the GFP tag itself can cause protein mislocalization. 
These experiments identified the omega cleavage site. Further domain exchange and 
mutagenesis studies identified which residues dictated cell wall or plasma membrane 
localization (Mao et al., 2008). 
2.7 Methodology 
Site-directed mutagenesis (i.e., targeted substitution of one or more nucleotides) in a gene 
was normally performed via overlap PCR and/or the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene/Agilent Technologies). The principle of these methods is the 
same. Complementary primers are designed with the nucleotide substitution at the desired 
site of the mutation. The primers are complementary to the region of the template with the 
wild-type residue. The template is a double-stranded DNA vector (usually a plasmid) 
containing a DNA clone of the region of interest. PCR with a high fidelity polymerase 
results in a plasmid with the mutation of the primer. The product is digested with DpnI, 
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which cleaves only the parental plasmid (template) because DpnI requires fully or hemi-
methylated DNA. (The parental plasmid is methylated by the E. coli host; DNA amplified by 
PCR is unmethylated.) The resulting DNA is then introduced into competent cells by 
transformation. Resulting plasmids are sequenced to confirm the mutation. It is also 
important to confirm that the mutation does not affect gene expression. Single-site 
mutagenesis has also been used to introduce silent mutations that result in construction of a 
restriction enzyme site in order to facilitate genetic manipulation (Cognetti et al., 2002; 
Schmalhorst et al., 2008). 
3. Insertional mutagenesis  
Insertional mutagenesis methods are commonly used in model fungi species. Although 
genomes are similar between model and medically important fungal species, there are still 
significant differences. Forward screens (screens for new genes that are involved in a 
phenotype, often using homologs) in model fungi will not identify genes important for 
pathogenesis, since these species are usually attenuated in virulence or are avirulent.  
Signaling pathways are shared among fungi, but downstream targets and regulation vary.  
It is estimated that only 61% of the essential genes in S. cerevisiae are also essential in C. 
albicans. There may be even more differences in filamentous fungi (Carr et al., 2010).  The 
advent of improved genetic techniques and whole-genome sequencing has dramatically 
improved the ability to perform forward screens in the medically important fungi.  One 
major drawback has been diploidism. Ways to circumvent the problem of diploidy have 
included parasexual genetics (non-meiotic conversion of a diploid to a haploid) (Carr et al., 
2010; Firon et al., 2003) and haploid insufficiency (a phenotype resulting from the loss of one 
allele in a diploid) (Uhl et al., 2003). Additional requirements that are species–specific 
include a ‘mutagen’ and an appropriate screen/phenotype. Insertional mutagenesis is 
normally now facilitated by transposons, but it is still necessary to identify transposons that 
work efficiently in the fungal species of choice. Much of the initial work demonstrated a bias 
for insertions, including a bias of non-coding regions.  A recent analysis of three transposons 
has identified Tn7 as having the least insertion bias in Candida glabrata (Green et al., 2012). 
This would probably translate to other fungal species whose genomes are also rich in A/T 
sequences. Certainly, in the post-genomics era, utilization of forward genetics approaches 
have increased due to the improved ability to identify the site of insertion. 
3.1 Selection of insertion mutants by complementation of auxotrophy  
Initial studies used complementation of auxotrophy as a ‘mutagen.’ Auxotrophic strains 
were transformed with plasmids carrying an auxotrophic marker (e.g., URA3/5). For 
example, in C. neoformans, capsule formation is associated with virulence.  Laccase is 
required for capsule formation. To identify the laccase gene, a ura-deficient mutant was 
transformed multiple times (to obtain independent mutants) with a URA construct that has 
an E. coli-specific replicon. When expressed in C. neoformans, the construct integrates 
randomly into the genome and complements the uracil auxotrophy. Transformants were 
selected for growth on medium lacking uracil. They were then screened on differential 
media that would identify strains with laccase deficiency due to a pigment change. Out of 
1000 transformants, nine strains with an altered phenotype were identified. Plasmid rescue 
was performed to identify the insertion point. (Plasmid rescue results from cleaving 
 
Site-Directed and Random Insertional Mutagenesis in Medically Important Fungi 
 
425 
genomic DNA with the appropriate restriction enzyme. The inserted fragment, along with a 
piece of the interrupted gene, is released.  The released DNA can circularize in the presence 
of ligase and form a plasmid that replicates in E. coli. Sequencing of the piece of interrupted 
gene is easily done and identifies the gene, which can then be cloned intact.). In this manner, 
a novel virulence attribute was identified, the vacuolar (H+) – ATPase subunit (VPH1) 
(Erickson et al., 2001).  In general, the drawbacks to the auxotrophic approach were 
inefficient integration, integration via homologous rather than non-homologous 
recombination, and difficulty in identification of the insertion site. 
3.2 Signature-tagged mutagenesis (STM)  
Signature-tagged mutagenesis is a method originally designed to identify genes required for 
pathogenesis (Hensel et al., 1995). A large number of mutants were created by insertional 
mutagenesis. The inserted DNA includes a unique oligonucleotide tag that resembles a 
‘barcode.’ In principle, up to 96 mutants can be inoculated into one host; strains not 
recovered are thought to harbor a mutation specific for in vivo growth (Hensel et al., 1995).  
This method was first used in Salmonella and was modified for C. glabrata, A. fumigatus, and 
C. neoformans (Brown et al., 2000; Cormack et al., 1999; Nelson et al., 2001). There were 
certain considerations in translating this approach to fungi, including larger genomes, non-
coding DNA, inefficient methods for insertion, selection of the appropriate host 
environment (Brown et al., 2000), and inoculation parameters (Nelson et al., 2001). These 
issues were addressed in the studies below (Brown et al., 2000; Nelson et al., 2001). 
The first studies were performed prior to the identification of useful transposons.  In order 
to identify virulence factors in A. fumigatus, two approaches were used to address random 
insertion of signature tags (Brown et al., 2000).  The first used restriction-mediated 
integration (REMI). Protoplasts of the recipient strain were transformed with clones with 
tags in the presence of the restriction enzyme KpnI (96 transformations).  The rationale was 
that these clones would integrate into KpnI sites randomly situated in the genome. The 
construction of the second library relied on ectopic integration, and Aspergillus was 
transformed with linearized clones (84 transformations).  The tags for the transformation 
constructs for both approaches were generated by PCR using templates developed for 
Salmonella typhimurium and cloned into a fungal transformation vector that carries a gene for 
hygromycin resistance (Brown et al., 2000). A similar approach was used for Cryptococcus 
neoformans, and the selection of insertions was based on ectopic integration of a linear 
plasmid conveying hygromycin resistance (Nelson et al., 2001). Further analysis 
demonstrated that integration was mostly random, except for one hotspot that was the 
actin/RPN10 promoter. In both cases, integration efficiency was lower than reported for 
bacteria. 
Many of the medically important fungi can cause different types of infections and/or 
colonize and infect multiple organs. Unlike bacteria, they do not have true ‘virulence 
factors’; but they do have virulence “attributes.“ Since in vivo murine models are involved, it 
is important to limit the number of mice used; and thus it is necessary to predetermine the 
appropriate model, the time points and the organs to harvest. For Aspergillus fumigatus, the 
STM libraries were tested in an immunosuppressed murine inhalation model (Brown et al., 
2000). For C. neoformans, Nelson et al. (2001) carefully determined the course of infection in a 
murine model and chose a time point that reflected attenuated or increased virulence based 
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on cfu (colony forming units) counts in the brain (Nelson et al., 2001). They also asked an 
interesting question: Would a virulent strain allow survival of an attenuated strain? For 
instance, if the virulent strain damaged endothelium, normally avirulent strains might 
theoretically have increased abilities to disseminate. They tested this by co-infecting with 
acapsular (avirulent) and capsular (virulent) strains. The avirulent acapsular strains were 
not recovered, and they concluded that virulent strains would not help avirulent strains 
(Nelson et al., 2001). However, this may not be true for all attenuated strains; and a strain’s 
ability to piggyback upon another will depend on its defect. This is a general drawback of 
STM and confirms that virulence tests with single strains have to be performed.  
Another important parameter is the number of strains that can be injected into a mouse and 
have an equal opportunity to survive. Nelson et al. (2001) did a prescreen with hygromycin 
and G418 resistant strains (100:1) and ascertained that it was possible to inoculate 100 
strains. However, studies with hybridization signals showed that they could not reliably 
detect more than 80 strains. Experiments were performed with pools of 48 strains. Six 
hundred seventy-two mutants were screened, and 39 gave different output signals. Twenty-
four of the mutants were tested singly in the mouse, and 6 of these had significant changes 
in virulence (Nelson et al., 2001). Brown et al. (2000) determined that subsequent 
hybridization efficiency was 80%, so, although they used pools of 96, they always inoculated 
2 mice per pool (Brown et al., 2000).  In total 4648 tagged strains were screened, and 35 
strains (0.8%) gave weak signals in the output pool after two rounds of STM. These strains 
were tested in a competitive inhibition infection, in which the attenuated strain was present 
as 50% of the inoculum. Nine strains showed a competitive disadvantage, and two of these 
demonstrated significantly reduced virulence. The site of the mutation of one strain was not 
identifiable; the second mutation was upstream of the PABA synthetase gene. Further 
analysis confirmed that pabaA is required for virulence.   
Cormack et al. (1999) exploited STM to construct a mutant library in C. glabrata (Cormack et 
al., 1999). Each strain could be easily identified by a distinct tag. Ninety-six unique strains 
were generated by integrating 96 different tags, flanked by identical primer sites, into the 
already disrupted URA3 locus. Since C. glabrata has an efficient system of non-homologous 
recombination, the Saccharomyces URA3 gene was used for random mutagenesis. 
Transformants were selected on media minus uracil. Pools of the 96 tagged strains were 
screened for adherence to human cultured epithelial cells. Out of 4800 mutants (50 pools of 
96), 31 mutants demonstrated aberrant adherence. Sixteen of these were non-adherent. 
Interestingly, 14/16 of these integrated into non-coding sequence upstream of the same 
gene, EPA1. This led to the identification of subtelomeric transcriptional silencing (Cormack 
et al., 1999). However, this method would not have identified EPA1 by traditional STM, 
since EPA1 null mutants are virulent in vivo.  
3.3 Transposon-mediated insertional mutagenesis  
Transposon technology has been used in pathogenic fungi to construct libraries, add epitope 
tags, and understand cellular processes. The technology has been adapted for diploid 
organisms using the parasexual cycle, haploid insufficiency, and homologous recombination 
(Carr et al., 2010; Davis et al., 2002; Firon et al., 2003; Juarez-Reyes et al., 2011; Spreghini et 
al., 2003; Uhl et al., 2003). The use of transposons has superseded auxotrophic and STM 
approaches. 
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Essential genes are often considered good drug targets. Firon et al. (2003) exploited the 
parasexual cycle to develop a transposon-mediated insertional mutagenesis protocol to 
identify essential genes in A. fumigatus (Firon et al., 2003). A diploid strain, homozygous 
auxotrophic for pyrimidines and heterozygous for a spore color marker, was randomly 
mutagenized with an imp160::pyrG transposon. The candidate mutant strains were induced 
to become haploid by the mitochondrial destabilizer, benomyl. The genotype of the parent 
strain allowed haploid progeny to be identified by pigmentation. Diploid strains were grey-
green, but haploid progenies were white or reddish. Replica plating identified the haploid 
progeny that harbored transposons. If haploid strains carried a transposon-inactivated 
allele, they expressed pyrG and grew on both selective (without uridine/uracil) and non-
selective media. Conversely, strains without a transposon grew only on non-selective media. 
If the transposon inactivated an essential gene, the haploid strain did not grow on either 
medium. With this approach, 3% of the haploid progeny of 2,386 diploid strains were found 
to be unable to grow on either medium and, therefore, possibly had mutations in essential 
genes. These strains were propagated further on selective media and haploid progeny could 
not be obtained from 1.2% of the resultant diploid revertants.  The sites of insertion were 
determined by 2-step PCR using semi-random primers and 5’-end transposon-specific 
primers (see Section 3.5.1). Ninety percent of insertion sites were identified (Firon et al., 
2003).  Since the insertion rate of the transposon into essential loci was lower than expected, 
additional transposon insertion sites were analyzed. Although an insertion site did not 
depend on genome sequence or chromosomal location, there did appear to be a bias toward 
noncoding regions (34%) (Firon et al., 2003). Carr et al. (2010), who observed that transposon 
mobilization could be induced at 10 °C, improved upon this approach. Therefore, using the 
same screen, 96 additional essential loci were identified.  They found no obvious bias of 
insertion in noncoding regions.  Interestingly, only half of the genes had essential homologs 
in Saccharomyces, confirming the necessity for species-specific screening.  
Uhl et al. (2003) developed a transposon mutant library in C. albicans.  Restriction enzyme-
digested C. albicans gDNA (genomic DNA) was mixed with a linearized donor transposon 
Tn7–containing plasmid. This plasmid harbored elements for replication in E. coli, for 
selection in both E. coli and C. albicans and a fungal lacZ reporter system. The fragments 
were ligated and introduced into E. coli by transformation. Plasmids were isolated from over 
200,000 transformants and batch isolated.  Transposon–gDNA junctions were sequenced in 
plasmids to confirm random integration. C. albicans was transformed with the Tn7-gDNA 
plasmids to give an 18,000-strain transposon mutant library. It was assumed that each strain 
had an independent insertion. That would mean there was a transposon approximately 
every 2.5 kb. However, only one allele of a gene was disrupted in these strains. (C. albicans is 
diploid, so one allele remains non-disrupted.) Uhl et al. (2003) exploited haploid 
insufficiency to screen for filamentation mutants, since heterozygote strains in genes 
involved in morphogenesis exhibit reduced filamentation.  This screen was rapid and 
successful for identifying processes that required genes sensitive to dosage effects. 
However, this certainly will not be the case for all genes involved in pathogenesis. 
Davis et al. (2002) constructed a transposon mutant library in C. albicans, but these strains 
harbored insertions in both alleles. This approach was based on a homologous 
recombination model that allowed the disruption of both alleles of C. albicans in one 
transformation step (Enloe et al., 2000). A cassette (UAU), which contains the URA3 gene 
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disrupted with a functional ARG4 gene, was inserted into transposon Tn7. the Tn7–UAU 
transposon was inserted randomly into a C. albicans library.  Digestion with the appropriate 
restriction enzyme released DNA fragments that contained C. albicans DNA interrupted 
with the Tn7-UAU transposon.  These fragments were used to transform C. albicans.  
Homology from the interrupted DNA allowed replacement of the chromosomal wild-type 
version by homologous recombination.  The chromosomal version was then mutated 
because it carried the Tn7-UAU transposon. Recombinants could be selected because 
transformation into the recipient ura- arg- Candida strain will confer arginine prototrophy. 
Occasionally the other intact copy of the gene acquired the transposon.  Thus, both copies of 
the gene were mutated.  Using arginine selection, homozygous mutants could not be 
distinguished from the heterozygotes.  However, in a small percentage of ARG+ 
transformants, the ARG4 gene is spontaneously looped out. If there were two copies of the 
transposon and if looping out occurred in one, it gave an ARG+, URA+ strain. Thus, both 
alleles were disrupted. This allowed for the construction of a large set of mutants, though it 
was still not as efficient as it would be for a haploid strain. This library is widely used by the 
Candida community (Davis et al., 2002; Norice et al., 2007; Park et al., 2009). 
Spreghini et al. (2003) exploited transposon mutagenesis to add an epitope to the putative 
cell wall protein, Dfg5p. Since conventional epitope tagging of amino and carboxyl termini 
was not an option, they wanted to identify an internal site which, when disrupted with a 
tag, did not compromise function. The Tn7 transposon was used to mutagenize the DFG5 
insert in a plasmid and insertions within DFG5 coding region were confirmed by 
sequencing. Then the mutagenized plasmid was redigested to get rid of the majority of Tn7, 
leaving only a 15-bp (base pair) insertion, which resulted in an insertion of 5 amino acids 
that did not disrupt function and could be recognized by an available antibody. The 
internally tagged DFG5 insert was then ligated into C. albicans vectors for further study 
(Spreghini et al., 2003). 
In the transposon examples above, mutagenesis was performed in vitro, and then 
mutagenized DNA was introduced into recipient strains. Magrini and Goldman (2001) took 
a different approach by directly mutagenizing Histoplasma capsulatum in vivo. The 
transformation cassette was a linear telomere vector (because the presence of a telomeric 
sequence is required for efficient homologous recombination in Histoplasma) containing the 
selection marker URA5, the MOS1 transposase gene regulated by a strong promoter, and the 
hygromycin resistance gene flanked by MOS1 terminal repeats to create a synthetic 
transposon.  Histoplasma transformants were selected in presence of 5-FOA (5-Fluoroorotic 
acid, which selects against URA5) to select for loss of the donor plasmid and on hygromycin 
for the presence of the synthetic transposon, which encodes hygromycin resistance. It is not 
known if this library has been utilized because T-DNA appears to be more commonly used 
in Histoplasma (see below).  
A novel use of random insertion was the analysis of subtelomeric silencing of C. glabrata 
adhesin genes. Learning where silencing occurred was accomplished by randomly placing a 
URA3 reporter at different distances from a telomere and examining where URA3 was 
silenced. The transposon Tn7–URA3 was introduced into a subtelomeric sequence of C. 
glabrata cloned on an E. coli plasmid. Resulting constructs were integrated into subtelomeric 
regions of C. glabrata by homologous recombination.  It was possible to select for ‘silenced’ 
URA3 on 5-FOA media (Juarez-Reyes et al., 2011). 
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3.4 Agrobacterium T-DNA 
Agrobacterium tumefaciens carries an approximately 200-kbp (kilobase pair) tumor-inducing 
(Ti) plasmid. A portion of this plasmid is called T-DNA. In plants, the T-DNA randomly 
inserts in the genome; and the outcome is a tumorous growth. This plasmid has been 
modified for genetic manipulation purposes to retain the insertional DNA (T-DNA). The 
plasmid vector can also replicate in E. coli and has cloning sites for additional DNA. T-DNA 
has been used to construct mutants with increased, reduced, or no expression of genes, 
depending on the plasmid used (Krysan et al., 1999). In the last decade, insertional 
mutagenesis via T-DNA has been successfully adapted for medically important fungi. In 
general, a fungal selectable marker is ligated into the Agrobacterium Ti plasmid within the T-
DNA region and introduced into A. tumefaciens by electroporation. Equal concentrations of 
A. tumefaciens carrying the delivery plasmid and target fungal strain are incubated together 
for varying lengths of time under conditions that mimic plant wound conditions, which are 
accomplished by low pH and the addition of acetosyringone. The T-DNA is transferred to 
the target organism by a conjugation-like mechanism.  A mutant that contains an insertion 
of T-DNA is selected with the appropriate fungal selective marker. 
Prior to T-DNA mutagenesis,  insertional mutagenesis was attempted by electroporation or 
biolistic transformation of naked DNA. Researchers have developed protocols that have 
improved the efficiency of transformation using T-DNA in C. neoformans (Idnurm et al., 
2004), Histoplasma and Blastomyces (Brandhorst et al., 2002; Edwards et al., 2011; Gauthier et 
al., 2010; Laskowski and Smulian, 2010; Marion et al., 2006; Smulian et al., 2007; Sullivan et 
al., 2002). In addition, T-DNA mutagenesis protocols have been developed for Coccidioides 
(Abuodeh et al., 2000), Trichoderma spp. (Cardoza et al., 2006; Dobrowolska and Staczek, 
2009; Yamada et al., 2009), and Penicillium marneffei (Kummasook et al., 2010; Zhang et al., 
2008). In C. neoformans, the use of T-DNA improved both the efficiency and the stability of 
transformation events. The resulting transformants also demonstrated less complicated 
integrations and less additional gene rearrangements. There did seem, however, to be a bias 
for promoter sequences. In one study, some of the integration events were not linked to 
NAT, the gene for the Nourseothricin resistance marker on the inserted DNA (Idnurm et al., 
2004). 
Blastomyces, in particular, is a challenge to transform, since it is multinucleate. Transforming 
DNA often integrates at multiple sites (Brandhorst et al., 2002). This is usually bypassed by 
transforming conidia or performing multiple rounds of selection to enrich for homokaryons 
(all the nuclei are genetically identical).  Sullivan et al. (2002) developed a protocol for both 
Histoplasma and Blastomyces. Many conditions were tested, including bacteria:yeast ratios, 
life stage of the recipient strain, and the choice of selectable marker. Interestingly, the 
efficiency of transformation was 5–10 times higher with uracil selection than with 
hygromycin selection. Southern analysis confirmed that integration was random, but there 
were often direct repeat concatemers in Blastomyces. There were clear improvements over 
electroporation, including increased efficiency, ability to use spores as the recipient, and 
single-site integrations (Sullivan et al., 2002).  Additional studies in Blastomyces using T-
DNA have identified genes involved in phase transition (Gauthier et al., 2010). 
T-DNA was used to identify genes in Histoplasma involved in pathogenesis in a novel high-
throughput macrophage-killing screen (Edwards et al., 2011). Transgenic (a novel gene was 
introduced) macrophage lines were constructed that constitutively expressed bacterial lacZ. 
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The activity of β- galactosidase, the product of lacZ, directly correlated to the number of 
macrophages. Thus, this line was used as a readout for macrophage killing. Over 2000 
Histoplasma transformants made from A. tumefaciens-treated Histoplasma cells were incubated 
with macrophages and screened for killing activity after 7 days. Three strains were less 
efficient in killing, and one was significantly inefficient in killing both transgenic and 
primary macrophages. Flanking sequences were identified by PCR and sequencing. The 
authors identified a new virulence gene in Histoplasma, a homolog of Hsp82 (Edwards et al., 
2011). 
Marion et al. (2006) performed a more comprehensive analysis of insertional mutagenesis in 
Histoplasma capsulatum using Agrobacterium-mediated transformation. Optimal co-incubation 
times, bacteria:yeast ratios and temperature were determined. Southern hybridization 
analysis showed that approximately 90% of the insertions were random and at a single site. 
Inverse PCR and plasmid rescue were used to identify the flanking sequences. Their results 
indicated that mutagenesis by T-DNA resulted in the absence of chromosomal 
rearrangements and deletions. The biological relevance of the T-DNA mutants was 
approached by screening for genes involved in the biosynthesis of α-(1, 3)–glucan, which is 
posited to be a virulence attribute. The absence of α-(1, 3)–glucan was easily visualized since 
colonies have a smooth, rather than rough, morphology. Approximately 50,000 insertional 
mutants were screened, and 25 had smooth morphology. Eighty-eight percent had single 
insertions and reduced α-(1, 3)–glucan. Five of twenty-two had distinct insertions in the α-
(1, 3)–glucan synthase gene (AGS1), which validated their screen. RNAi technology 
(synthetic inhibitory RNA) was used to confirm the insertion mutant phenotype with the 
wild-type allele. The phenotypes of the two other mutants were confirmed. One mutation 
was in UGP1 (previously reported to play a role in glucan synthesis).  The other mutation 
was in the amylase gene, which was previously unreported to play a role (Marion et al., 
2006).  
The use of T-DNA in Histoplasma has provided additional information. As with all genetic 
manipulations, it is important to confirm that the mutation is responsible for the ensuing 
phenotype. Smulian et al. (2007) wanted to make GFP-expressing strains and used 
hygromycin resistance as a marker and T-DNA as the tool for integration. It turned out that 
all the transformants were hypervirulent. Site-directed mutagenesis of the hygromycin 
resistant gene, hph, confirmed that the increased virulence was due to the acquisition of 
hygromycin resistance. One mutant actually gained the ability to form cleistothecia, a 
mating structure that was not present in the parent strain. This phenotypic trait was not due 
to the hph gene; and, thus, the strain may be used as a tool to study mating in Histoplasma 
(Laskowski and Smulian, 2010).  
3.5 Methodologies to identify the site of insertion  
3.5.1 Two-step PCR 
In the first step of two-step PCR (Chun et al., 1997), sequence on one side of the insertion site 
is amplified with a degenerate primer and a primer homologous to the sequence in one of 
the ends of the inserted DNA. (There are two end-specific primers. A primer specific for 
only one end is used. Note that a tranposon can insert in either orientation.) The degenerate 
primer contains 20 nucleotides of defined sequence at the 5’-end, 10 nucleotides of 
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degenerate sequence (i.e., all 4 nucleotides are used at each position for synthesis) + GATAT 
at the 3’-end. The sequence GATAT is  predicted to occur every 600 bp in the yeast genome. 
The second step amplifies the first PCR product with two non-degenerate primers. The 
forward primer contains the 20 nt (nucleotides) of defined sequence in the degenerate 
primer. The reverse primer is immediately 3’ (antisense strand) to the insertion-specific 
primer used in the first PCR reaction to guarantee that the desired DNA is amplified (Chun 
et al., 1997). This method was originally defined in Saccharomyces and was successfully used 
to identify transposon insertions in A. fumigatus (Carr et al., 2010; Firon et al., 2003). 
3.5.2 Thermal asymmetric interlaced PCR (TAIL PCR) 
TAIL PCR (Liu and Whittier, 1995) is another method to identify sequences flanking 
insertions. It is a modified version of hemispecific (one-sided) PCR. The purpose is to favor 
amplification of the desired product. It uses specific primers homologous to DNA in the 
integrating cassette or plasmid and a degenerate primer that can anneal to the gDNA 
flanking the insertion. The strategy is that the specific primers are long, nested, and have a 
high Tm; the degenerate primer is short and has a low Tm. The first five cycles are high 
stringency cycles to favor annealing to and linear amplification from the specific primer. 
Then there is one low stringency cycle to allow the degenerate primer to anneal.  Because 
there are now several copies of the gDNA adjacent to the insertion, the chance of the 
degenerate primer annealing to the desired product is increased.  However, other products 
might form from the primers finding additional annealing sites in the genome. Using a 
second and a third primer completely homologous to the inserted DNA will favor the 
desired product that is made from both the specific and degenerate primers instead of either 
one alone. This is accomplished by interlacing reduced stringency and high stringency 
cycles. 
4. Closing remarks 
Site-directed and insertional mutagenesis are techniques that can be used to advance our 
understanding of the pathogenesis of medically important fungi. The exploitation of these 
tools has resulted in a better understanding of drug-resistant mechanisms, transcription  
factors, signaling pathways and vital cellular processes. Site-directed mutagenesis could be 
better utilized to decipher the functions of essential and multi-functional genes.  While all 
approaches cannot be used in the always-diploid strains, transposon-mediated insertional 
mutagenesis can be used to construct libraries. Additionally, T-DNA can be used to improve 
transformation efficiency in dimorphic fungi and in C. neoformans.  
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